Naturally occurring and synthetic peptides acting on nicotinic acetylcholine receptors

Current Pharmaceutical Design

Volumn 15, Issue 21, 2009, Pages 2430-2452

  Kasheverov, Igor E ^a   Utkin, Yuri N ^a   Tsetlin, Victor I ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

conotoxins; Nicotinic acetylcholine receptor; Peptides

Indexed keywords

ALPHA CONOTOXIN; ALPHA NEUROTOXIN; AMYLOID PROTEIN; APOLIPOPROTEIN E; CALCITONIN GENE RELATED PEPTIDE; CHROMOGRANIN A; CONOTOXIN; GLYCOPROTEIN; NEUROTOXIN; NICOTINIC RECEPTOR; RABIES VACCINE; SUBSTANCE P; TOXIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; WAGLERIN;

ALZHEIMER DISEASE; ANTIBODY PRODUCTION; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; CHRONIC PAIN; DRUG BINDING; HOST PATHOGEN INTERACTION; LIGAND BINDING; NEUROMUSCULAR TRANSMISSION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RABIES; RABIES VIRUS; REVIEW; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANIMALS; BINDING SITES; CONOTOXINS; CROTALID VENOMS; GLYCOPROTEINS; HIV ENVELOPE PROTEIN GP120; LIGANDS; MOLECULAR SEQUENCE DATA; NEUROTOXINS; NICOTINIC ANTAGONISTS; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, NICOTINIC; SUBSTANCE P;

EID: 69249097477     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209788682316     Document Type: Review

References (257)

1. Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 2006; 27: 482-91.
2. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 2007; 47: 699-729.
3. Wells GB. Structural answers and persistent questions about how nicotinic receptors work. Front Biosci 2008; 13: 5479-510.
4. Grando SA. Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors. J Pharmacol Sci 2008; 106: 174-9.
5. Nastopoulos V, Kanellopoulos PN, Tsernoglou D. Structure of dimeric and monomeric erabutoxin a refined at 1.5 Å resolution. Acta Crystallogr D Biol Crystallogr 1998; 54: 964-74.
6. Karlsson E. In: Lee CY Ed, Handbook of experimental pharmacology, vol. 52. Berlin, Springer Verlag. 1978; 159-212.
7. Tsetlin VI, Arseniev AS, Utkin YN, Gurevich AZ, Senyavina LB, Bystrov VF, et al. Conformational studies of neurotoxin II from Naja naja oxiana. Selective N-acylation, circular dichroism and nuclear-magnetic-resonance study of acylation products. Eur J Biochem 1979; 94: 337-46.
8. Juillerat MA, Schwendimann B, Hauert J, Fulpius BW, Bargetzi JP. Specific binding to isolated acetylcholine receptor of a synthetic peptide duplicating the sequence of the presumed active center of a lethal toxin from snake venom. J Biol Chem 1982; 257: 2901-7.
9. Miller RA, Tu AT. Structure-function relationship of lapemis toxin: A synthetic approach. Arch Biochem Biophys 1991; 29: 69-75.
10. Lentz TL. Structure-function relationships of curaremimetic neurotoxin loop 2 and of a structurally similar segment of rabies virus glycoprotein in their interaction with the nicotinic acetylcholine receptor. Biochemistry 1991; 30: 10949-57.
11. Léonetti M, Pillet L, Maillere B, Lamthanh H, Frachon P, Couderc J, et al. Immunization with a peptide having both T cell and conformationally restricted B cell epitopes elicits neutralizing antisera against a snake neurotoxin. J Immunol 1990; 145: 4214-21.
12. Lentz TL, Wilson PT, Hawrot E, Speicher DW. Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science 1984; 226: 847-8.
13. Lentz TL, Hawrot E, Donnelly-Roberts D, Wilson PT. Synthetic peptides in the study of the interaction of rabies virus and the acetylcholine receptor. Adv Biochem Psychopharmacol 1988; 44: 57-71.
14. Lentz TL, Burrage TG, Smith AL, Crick J, Tignor GH. Is the acetylcholine receptor a rabies virus receptor? Science.1982; 215: 182-4.
15. Lentz TL, Benson RJ, Klimowicz D, Wilson PT, Hawrot E. Binding of rabies virus to purified Torpedo acetylcholine receptor. Brain Res 1986; 387: 211-9.
16. Lentz TL, Hawrot E, Wilson PT. Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor. Proteins 1987; 2: 298-307.
17. Donnelly-Roberts DL, Lentz TL. Synthetic peptides of neurotoxins and rabies virus glycoprotein behave as antagonists in a functional assay for the acetylcholine receptor. Pept Res 1989; 2: 221-6.
18. Donnelly-Roberts DL, Lentz TL. Structural and conformational similarity between synthetic peptides of curaremimetic neurotoxins and rabies virus glycoprotein. Brain Res Mol Brain Res 1991; 11: 107-13.
19. Rustici M, Santucci A, Lozzi L, Petreni S, Spreafico A, Neri P, et al. A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor. J Mol Recognit 1989; 2: 51-5.
20. Langevin C, Jaaro H, Bressanelli S, Fainzilber M, Tuffereau C. Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J Biol Chem 2002; 277: 37655-62.
21. Lafon M. Rabies virus receptors. J Neurovirol 2005; 11: 82-7.
22. Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007; 448: 39-43.
23. Neri P, Bracci L, Rustici M, Santucci A. Sequence homology between HIV gp120, rabies virus glycoprotein, and snake venom neurotoxins. Is the nicotinic acetylcholine receptor an HIV receptor? Arch Virol 1990; 114: 265-9.
24. Bracci L, Ballas SK, Spreafico A, Neri P. Molecular mimicry between the rabies virus glycoprotein and human immunodeficiency virus-1 GP120: cross-reacting antibodies induced by rabies vaccination. Blood 1997; 90: 3623-8.
25. Rock RB, Gekker G, Aravalli RN, Hu S, Sheng WS, Peterson PK. Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-β1. J Neuroimmune Pharmacol 2008; 3: 143-9.
26. Yoshikawa Y, Yamanouchi K, Takasu T, Rauf S, Ahmed A. Structural homology between hemagglutinin (HA) of measles virus and the active site of long neurotoxins. Virus Genes 1991; 5: 57-67.
27. Marinou M, Tzartos SJ. Identification of regions involved in the binding of α-Bgt to the human α7 neuronal nicotinic acetylcholine receptor using synthetic peptides. Biochem J 2003; 372: 543-54.
28. Mulac-Jericevic B, Atassi MZ. Profile of the α-bungarotoxin-binding regions on the extracellular part of the α-chain of Torpedo californica acetylcholine receptor. Biochem J 1987; 248: 847-52.
29. Klukas O, Peshenko IA, Rodionov IL, Teliakova OV, Utkin IuN, Tsetlin VI. Fragments 183-198 and 125-145 of the α-subunits of the Torpedo californica nicotinic acetylcholinergic receptor binds α-bungarotoxin and neurotoxin II from Naja naja oxiana. Bioorg Khim 1995; 21: 152-5.
30. Tsetlin VI, Hucho F. Snake and snail toxins acting on nicotinic acetylcholine receptors: Fundamental aspects and medical applications. FEBS Lett 2004; 557: 9-13.
31. Nirthanan S, Gwee MC. Three-finger α-neurotoxins and the nicotinic acetylcholine receptor, forty years on. J Pharmacol Sci 2004; 94: 1-17.
32. Bourne Y, Talley TT, Hansen SB, Taylor P, Marchot P. Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake α-neurotoxins and nicotinic receptors. EMBO J 2005; 24: 1512-22
33. Dellisanti CD, Yao Y, Stroud JC, Wang ZZ, Chen L. Crystal structure of the extracellular domain of nAChR α1 bound to α-bungarotoxin at 1.94 Å resolution. Nat Neurosci 2007; 10: 953-62.
34. Akasu T, Kojima M, Koketsu K. Substance P modulates the sensitivity of the nicotinic receptor in amphibian cholinergic transmission. Br J Pharmacol 1983; 80: 123-31.
35. Weiland GA, Durkin JA, Henley JM, Simasko SM. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors. Mol Pharmacol 1987; 32: 625-32.
36. Min CK, Weiland GA. Effects of substance P on the binding of agonists to the nicotinic acetylcholine receptor of Torpedo electroplaque. J Neurochem 1993; 60: 2238-46.
37. Stafford GA, Oswald RE, Weiland GA. The β subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition. Mol Pharmacol 1994; 45: 758-62.
38. Stafford GA, Oswald RE, Figl A, Cohen BN, Weiland GA. Two domains of the β subunit of neuronal nicotinic acetylcholine receptors contribute to the affinity of substance P. J Pharmacol Exp Ther 1998; 286: 619-26.
39. Min CK, Owens J, Weiland GA. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque. Mol Pharmacol 1994; 45: 221-7.
40. Blanton MP, Li YM, Stimson ER, Maggio JE, Cohen JB. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor δ subunit. Mol Pharmacol 1994; 46: 1048-55.
41. Kasheverov IE, Utkin YN, Franke P, Tsetlin VI. Substance P derivatives with photoactivatable labels in the N-terminal part of the molecule. J Pept Res 1997; 50: 408-14.
42. Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, et al. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. Clin Invest 1997; 100: 1623-33.
43. Taupenot L, Mahata SK, Mahata M, Parmer RJ, O'Connor DT. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: Implications for nicotinic cholinergic antagonism. Regul Pept 2000; 95: 9-17.
44. Herrero CJ, Alés E, Pintado AJ, López MG, García-Palomero E, Mahata SK, et al. Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis. J Neurosci 2002; 22: 377-88.
45. Gay EA, Klein RC, Yakel JL. Apolipoprotein E-derived peptides block α7 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 2006; 316: 835-42.
46. Gay EA, Bienstock RJ, Lamb PW, Yakel JL. Structural determinates for apolipoprotein E-derived peptide interaction with the α7 nicotinic acetylcholine receptor. Mol Pharmacol 2007; 72: 838-49.
47. Di Angelantonio S, Costa V, Carloni P, Messori L, Nistri A. A novel class of peptides with facilitating action on neuronal nicotinic receptors of rat chromaffin cells in vitro: Functional and molecular dynamics studies. Mol Pharmacol 2002; 61: 43-54.
48. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB. β-Amyloid(1-42) binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 2000; 275: 5626-32.
49. Dineley KT. β-amyloid peptide - nicotinic acetylcholine receptor interaction: The two faces of health and disease. Front Biosci 2007; 12: 5030-8.
50. Wang HY, Lee DH, Davis CB, Shank RP. Amyloid peptide Aβ(1-42) binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors. J Neurochem 2000; 75: 1155-61.
51. Dineley KT, Bell KA, Bui D, Sweatt JD. β-Amyloid peptide activates α 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 2002; 277: 25056-61.
52. Fu W, Jhamandas JH. β-amyloid peptide activates non-α7 nicotinic acetylcholine receptors in rat basal forebrain neurons. J Neurophysiol 2003; 90: 3130-6.
53. Wu J, Kuo YP, George AA, Xu L, Hu J, Lukas RJ. β-Amyloid directly inhibits human α4β2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. J Biol Chem 2004; 279: 37842-51.
54. Pym L, Kemp M, Raymond-Delpech V, Buckingham S, Boyd CA, et al. Subtype-specific actions of β-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (α7, α4β2, α3β4) expressed in Xenopus laevis oocytes. Br J Pharmacol 2005; 146: 964-71.
55. Pym LJ, Buckingham SD, Tsetlin V, Boyd CA, Sattelle DB. The Aβ1-42M35C mutated amyloid peptide Aβ1-42 and the 25-35 fragment fail to mimic the subtype-specificity of actions on recombinant human nicotinic acetylcholine receptors (α7, α4β2, α3β4). Neurosci Lett 2007; 427: 28-33.
56. Small DH, Maksel D, Kerr ML, Ng J, Hou X, Chu C, et al. The β-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor. J Neurochem 2007; 101: 1527-38.
57. Magdesian MH, Nery AA, Martins AH, Juliano MA, Juliano L, Ulrich H, et al. Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid β. J Biol Chem 2005; 280: 31085-90.
58. Espinoza-Fonseca LM, Trujillo-Ferrara JG. Fully flexible docking models of the complex between α7 nicotinic receptor avd a potent heptapeptide inhibitor of the β-amyloid peptide binding. Bioorg Med Chem Lett 2006; 16: 3519-23.
59. Espinoza-Fonseca LM. Molecular docking of four β-amyloid1-42 fragments on the α7 nicotinic receptor: Delineating the binding site of the Aβ peptides. Biochem Biophys Res Commun 2004; 323: 1191-6.
60. Stevens TR, Krueger SR, Fitzsimonds RM, Picciotto MP. Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation. J Neurosci 2003; 23: 10093-9.
61. Shaw S, Bencherif M, Marrero MB. Janus kinase 2, an early target of α 7 nicotinic acetylcholine receptor-mediated neuroprotection against Aβ-(1-42) amyloid. J Biol Chem 2002; 277: 44920-4.
62. Tsai MC, Hsieh WH, Smith LA, Lee CY. Effects of waglerin-I on neuromuscular transmission of mouse nerve-muscle preparations. Toxicon 1995; 33: 363-71.
63. Schmidt JJ, Weinstein SA. Structure-function studies of waglerin I, a lethal peptide from the venom of Wagler's pit viper, Trimeresurus wagleri. Toxicon 1995; 33: 1043-9.
64. Chuang LC, Yu HM, Chen C, Huang TH, Wu SH, Wang KT. Determination of three-dimensional solution structure of waglerin I, a toxin from Trimeresurus wagleri, using 2D-NMR and molecular dynamics simulation. Biochim Biophys Acta 1996; 1292: 145-55.
65. Sellin LC, Mattila K, Annila A, Schmidt JJ, McArdle JJ, Hyvönen M, et al. Conformational analysis of a toxic peptide from Trimeresurus wagleri which blocks the nicotinic acetylcholine receptor. Biophys J 1996; 70: 3-13.
66. Hsiao YM, Chuang CC, Chuang LC, Yu HM, Wang KT, Chiou SH, et al. Protein engineering of venom toxins by synthetic approach and NMR dynamic simulation: Status of basic amino acid residues in waglerin I. Biochem Biophys Res Commun 1996; 227: 59-63.
67. McArdle JJ, Lentz TL, Witzemann V, Schwarz H, Weinstein SA, Schmidt JJ. Waglerin-1 selectively blocks the ε form of the muscle nicotinic acetylcholine receptor. J Pharmacol Exp Ther 1999; 289: 543-50.
68. Lin WW, Smith LA, Lee CY. A study on the cause of death due to waglerin-I, a toxin from Trimeresurus wagleri. Toxicon 1995; 33: 111-4.
69. Molles BE, Rezai P, Kline EF, McArdle JJ, Sine SM, Taylor P. Identification of residues at the α and ε subunit interfaces mediating specieσ selectivity of Waglerin-1 for nicotinic acetylcholine receptors. J Biol Chem 2002; 277: 5433-40.
70. Molles BE, Tsigelny I, Nguyen PD, Gao SX, Sine SM, Taylor P. Residues in the ε subunit of the nicotinic acetylcholine receptor interact to confer selectivity of waglerin-1 for the α-ε subunit interface site. Biochemistry 2002; 41: 7895-906.
71. Norton RS, Olivera BM. Conotoxins down under. Toxicon 2006; 48: 780-98.
72. Terlau H, Olivera BM. Conus venoms: A rich source of novel ion channel-targeted peptides. Physiol Rev 2004; 84: 41-68.
73. Nicke A, Wonnacott S, Lewis RJ. α-Conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. Eur J Biochem 2004; 271: 2305-19.
74. Janes RW. α-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses. Curr Opin Pharmacol 2005; 5: 280-92.
75. Ellison M, Olivera BM. α4/3 Conotoxins: Phylogenetic distribution, functional properties, and structure-function insights. Chem Rec 2007; 7: 341-53.
76. Livett BG, Sandall DW, Keays D, Down J, Gayler KR, Satkunanathan N, et al. Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon 2006; 48: 810-29.
77. Shon KJ, Grilley M, Jacobsen R, Cartier GE, Hopkins C, Gray WR, et al. A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from Conus purpurascens venom. Biochemistry 1997; 36: 9581-7.
78. Van Wagoner RM, Ireland CM. An improved solution structure for Ψ-conotoxin PIIIE. Biochemistry 2003; 42: 6347-52.
79. Van Wagoner RM, Jacobsen RB, Olivera BM, Ireland CM. Characterization and three-dimensional structure determination of Ψ-conotoxin PIIIF, a novel noncompetitive antagonist of nicotinic acetylcholine receptors. Biochemistry 2003; 42: 6353-62.
80. Lluisma AO, López-Vera E, Bulaj G, Watkins M, Olivera BM. Characterization of a novel Ψ-conotoxin from Conus parius Reeve. Toxicon 2008; 51: 174-80.
81. Teichert RW, Rivier J, Dykert J, Cervini L, Gulyas J, Bulaj G, et al. αA-Conotoxin OIVA defines a new αA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors. Toxicon 2004; 44: 207-14.
82. Teichert RW, López-Vera E, Gulyas J, Watkins M, Rivier J, Olivera BM. Definition and characterization of the short αAconotoxins: A single residue determines dissociation kinetics from the fetal muscle nicotinic acetylcholine receptor. Biochemistry 2006; 45: 1304-12.
83. Teichert RW, Rivier J, Torres J, Dykert J, Miller C, Olivera BM. A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor. J Neurosci 2005; 25: 732-6.
84. Hopkins C, Grilley M, Miller C, Shon KJ, Cruz LJ, Gray WR, et al. A new family of Conus peptides targeted to the nicotinic acetylcholine receptor. J Biol Chem, 1995, 270, 22361-7.
85. Han KH, Hwang KJ, Kim SM, Kim SK, Gray WR, Olivera BM, et al. NMR structure determination of a novel conotoxin, [Pro7,13] αA-conotoxin PIVA. Biochemistry 1997; 36: 1669-77.
86. Jacobsen R, Yoshikami D, Ellison M, Martinez J, Gray WR, Cartier GE, et al. Differential targeting of nicotinic acetylcholine receptors by novel αA-conotoxins. J Biol Chem 1997; 272: 22531-7.
87. Chi SW, Park KH, Suk JE, Olivera BM, McIntosh JM, Han KH. Solution conformation of αA-conotoxin EIVA, a potent neuromuscular nicotinic acetylcholine receptor antagonist from Conus ermineus. J Biol Chem 2003; 278: 42208-13.
88. Jimenez EC, Olivera BM, Teichert RW. αC-conotoxin PrXA: A new family of nicotinic acetylcholine receptor antagonists. Biochemistry 2007; 46: 8717-24.
89. Teichert RW, Jimenez EC, Olivera BM. αS-conotoxin RVIIIA: A structurally unique conotoxin that broadly targets nicotinic acetylcholine receptors. Biochemistry 2005; 44: 7897-902.
90. Teichert RW, Garcia CC, Potian JG, Schmidt JJ, Witzemann V, Olivera BM, et al. Peptide-toxin tools for probing the expression and function of fetal and adult subtypes of the nicotinic acetylcholine receptor. Ann N Y Acad Sci 2008; 1132: 61-70.
91. Loughnan M, Nicke A, Jones A, Schroeder CI, Nevin ST, Adams DJ, et al. Identification of a novel class of nicotinic receptor antagonists: Dimeric conotoxins VxXIIA, VxXIIB, and VxXIIC from Conus vexillum. J Biol Chem 2006; 281: 24745-55.
92. Chiappinelli VA, Wolf KM. κ-Neurotoxins: Heterodimer formation between different neuronal nicotinic receptor antagonists. Biochemistry 1989; 28: 8543-7.
93. Osipov AV, Kasheverov IE, Makarova YV, Starkov VG, Vorontsova OV, Ziganshin RK, et al. Naturally occurring disul-fide-bound dimers of three-fingered toxins: A paradigm for biological activity diversification. J Biol Chem 2008; 283: 14571-80.
94. Ramilo CA, Zafaralla GC, Nadasdi L, Hammerland LG, Yoshikami D, Gray WR, et al. Novel α- and ω-conotoxins from Conus striatus venom. Biochemistry 1992; 31: 9919-26.
95. Peng C, Tang S, Pi C, Liu J, Wang F, Wang L, et al. Discovery of a novel class of conotoxin from Conus litteratus, lt14a, with a unique cysteine pattern. Peptides 2006; 27: 2174-81.
96. 1-adrenoreceptor antagonism by the conopeptide r-TIA. J Biol Chem 2003; 278: 34451-7.
97. Gehrmann J, Alewood PF, Craik DJ. Structure determination of the three disulfide bond isomers of α-conotoxin GI: A model for the role of disulfide bonds in structural stability. J Mol Biol 1998; 278: 401-15
98. Hashimoto K, Uchida S, Yoshida H, Nishiuchi Y, Sakakibara S, Yukari K. Structure-activity relations of conotoxins at the neuromuscular junction. Eur J Pharmacol 1985; 118: 351-4.
99. Jin AH, Brandstaetter H, Nevin ST, Tan CC, Clark RJ, Adams DJ, et al. Structure of α-conotoxin BuIA: Influences of disulfide connectivity on structural dynamics. BMC Struct Biol 2007; 7: 28.
100. Kang TS, Radić Z, Talley TT, Jois SD, Taylor P, Kini RM. Protein folding determinants: Structural features determining alternative disulfide pairing in α- and χ/λ-conotoxins. Biochemistry 2007; 46: 3338-55.
101. Clark RJ, Daly NL, Halai R, Nevin ST, Adams DJ, Craik DJ. The three-dimensional structure of the analgesic α-conotoxin, RgIA. FEBS Lett 2008; 582: 597-602.
102. Dutton JL, Bansal PS, Hogg RC, Adams DJ, Alewood PF, Craik DJ. A new level of conotoxin diversity, a non-native disulfide bond connectivity in α-conotoxin AuIB reduces structural definition but increases biological activity. J Biol Chem 2002; 277: 48849-57.
103. 1-adrenoceptor and noradrenaline transporter. Nat Neurosci 2001; 4: 902-7.
104. Gray WR, Luque A, Olivera BM, Barrett J, Cruz LJ. Peptide toxins from Conus geographus venom. J Biol Chem 1981; 256: 4734-40.
105. 1H nuclear magnetic resonance spectroscopy and distance geometry calculations. Biochemistry 1989; 28: 4853-60.
106. Maslennikov IV, Sobol AG, Gladky KV, Lugovskoy AA, Ostrovsky AG, Tsetlin VI, et al. Two distinct structures of α-conotoxin GI in aqueous solution. Eur J Biochem 1998; 254: 238-47.
107. Guddat LW, Martin JA, Shan L, Edmundson AB, Gray WR. Three-dimensional structure of the α-conotoxin GI at 1.2 Å resolution. Biochemistry 1996; 35: 11329-35.
108. McManus OB, Musick JR, Gonzalez C. Peptides isolated from the venom of Conus geographus block neuromuscular transmission. Neurosci Lett 1981; 25: 57-62.
109. Hann RM, Pagán OR, Eterović VA. The α-conotoxins GI and MI distinguish between the nicotinic acetylcholine receptor agonist sites while SI does not. Biochemistry 1994; 33: 14058-63.
110. Groebe DR, Dumm JM, Levitan ES, Abramson SN. α-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors. Mol Pharmacol 1995; 48: 105-11.
111. Kasheverov IE, Zhmak MN, Vulfius CA, Gorbacheva EV, Mordvintsev DY, Utkin YN, et al. α-Conotoxin analogs with additional positive charge show increased selectivity towards Torpedo californica and some neuronal subtypes of nicotinic acetylcholine receptors. FEBS J 2006; 273: 4470-81.
112. Luetje CW, Wada K, Rogers S, Abramson SN, Tsuji K, Heinemann S, et al. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J Neurochem 1990; 55: 632-40.
113. McIntosh M, Cruz LJ, Hunkapiller MW, Gray WR Olivera BM. Isolation and structure of a peptide toxin from the marine snail Conus magus. Arch Biochem Biophys 1982; 218: 329-34.
114. Gray WR, Rivier JE, Galyean R, Cruz LJ, Olivera BM. Conotoxin MI. Disulfide bonding and conformational states. J Biol Chem 1983; 258: 12247-51.
115. 1H-NMR spectroscopy and molecular dynamics simulation with the explicit solvent water. Biochim Biophys Acta 1997; 1343: 327-34
116. Jacobsen RB, DelaCruz RG, Grose JH, McIntosh JM, Yoshikami D, Olivera BM. Critical residues influence the affinity and selectivity of α-conotoxin MI for nicotinic acetylcholine receptors. Biochemistry 1999; 38: 13310-5.
117. Luo S, McIntosh JM. Iodo-α-conotoxin MI selectively binds the α/δ subunit interface of muscle nicotinic acetylcholine receptors. Biochemistry 2004; 43: 6656-62.
118. Zafaralla GC, Ramilo C, Gray WR, Karlstrom R, Olivera BM, Cruz LJ. Phylogenetic specificity of cholinergic ligands: α-conotoxin SI. Biochemistry 1988; 27: 7102-5.
119. Benie AJ, Whitford D, Hargittai B, Barany G, Janes RW. Solution structure of α-conotoxin SI. FEBS Lett 2000; 476: 287-95.
120. Groebe DR, Gray WR, Abramson SN. Determinants involved in the affinity of α-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors. Biochemistry 1997; 36: 6469-74.
121. Hann RM, Pagan OR, Gregory LM, Jacome T, Eterovic VA. The 9-arginine residue of α-conotoxin GI is responsible for its selective high affinity for the αγ agonist site on the electric organ acetylcholine receptor. Biochemistry 1997; 36: 9051-6.
122. Myers RA, Zafaralla GC, Gray WR, Abbott J, Cruz LJ, Olivera BM. α-Conotoxins, small peptide probes of nicotinic acetylcholine receptors. Biochemistry 1991; 30: 9370-7.
123. Favreau P, Krimm I, Le Gall F, Bobenrieth MJ, Lamthanh H, Bouet F, et al. Biochemical characterization and nuclear magnetic resonance structure of novel α-conotoxins isolated from the venom of Conus consors. Biochemistry 1999; 38: 6317-26.
124. Liu L, Chew G, Hawrot E, Chi C, Wang C. Two potent α3/5 conotoxins from piscivorous Conus achatinus. Acta Biochim Biophys Sin (Shanghai) 2007; 39: 438-44.
125. McIntosh JM, Yoshikami D, Mahe E, Nielsen DB, Rivier JE, Gray WR, et al. A nicotinic acetylcholine receptor ligand of unique specificity, α-conotoxin ImI. J Biol Chem 1994; 269: 16733-9.
126. Maslennikov IV, Shenkarev ZO, Zhmak MN, Ivanov VT, Methfessel C, Tsetlin VI, et al. NMR spatial structure of α-conotoxin ImI reveals a common scaffold in snail and snake toxins recognizing neuronal nicotinic acetylcholine receptors. FEBS Lett 1999; 444: 275-80.
127. Gouda H, Hirono S. Solution structure of α-conotoxin ImI determined by two-dimensional NMR spectroscopy. Biochim Biophys Acta 1999; 1431: 384-94.
128. 1H nuclear magnetic resonance. J Med Chem 1999; 42: 2364-72.
129. Rogers JP, Luginbuhl P, Shen GS, McCabe RT, Stevens RC, Wemmer DE. NMR solution structure of α-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors. Biochemistry 1999; 38: 3874-82.
130. Johnson DS, Martinez J, Elgoyhen AB, Heinemann SF, McIntosh JM. α-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: Preferential inhibition of homomeric α7 and α9 receptors. Mol Pharmacol 1995; 48: 194-9.
131. Pereira EF, Alkondon M, McIntosh JM, Albuquerque E. X. α-Conotoxin-ImI: A competitive antagonist at α-bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons. J Pharmacol Exp Ther 1996; 278: 1472-83.
132. Ellison M, McIntosh JM, Olivera BM. α-Conotoxins ImI and ImII. Similar α7 nicotinic receptor antagonists act at different sites. J Biol Chem 2003; 278: 757-64.
133. Ellison M, Haberlandt C, Gomez-Casati ME, Watkins M, Elgoyhen AB, McIntosh JM, et al. α-RgIA: A novel conotoxin that specifically and potently blocks the α9α10 nAChR. Biochemistry 2006; 45: 1511-7.
134. Ellison M, Gao F, Wang HL, Sine SM, McIntosh JM, Olivera BM. α-Conotoxins ImI and ImII target distinct regions of the human α7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes. Biochemistry 2004; 43: 16019-26.
135. Broxton NM, Down JG, Gehrmann J, Alewood PF, Satchell DG, Livett BG. α-Conotoxin ImI inhibits the α-bungarotoxin-resistant nicotinic response in bovine adrenal chromaffin cells. J Neurochem 1999; 72: 1656-62.
136. Vincler M, Wittenauer S, Parker R, Ellison M, Olivera BM, McIntosh JM. Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 2006; 103: 17880-4.
137. Ellison M, Feng ZP, Park AJ, Zhang X, Olivera BM, McIntosh JM, et al. α-RgIA, a novel conotoxin that blocks the α9α10 nAChR: Structure and identification of key receptor-binding residues. J Mol Biol 2008; 377: 1216-27.
138. Azam L, Dowell C, Watkins M, Stitzel JA, Olivera BM, McIntosh JM. α-Conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors. J Biol Chem 2005; 280: 80-7.
139. Chi SW, Kim DH, Olivera BM, McIntosh JM, Han KH. NMR structure determination of α-conotoxin BuIA, a novel neuronal nicotinic acetylcholine receptor antagonist with an unusual 4/4 disulfide scaffold. Biochem Biophys Res Commun 2006; 349: 1228-34.
140. López-Vera E, Jacobsen RB, Ellison M, Olivera BM, Teichert RW. A novel alpha conotoxin (α-PIB) isolated from C. purpurascens is selective for skeletal muscle nicotinic acetylcholine receptors. Toxicon 2007; 49: 1193-9.
141. Luo S, Kulak JM, Cartier GE, Jacobsen RB, Yoshikami D, Olivera BM, et al. α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J Neurosci 1998; 18: 8571-9.
142. 4 subtype-selective neuronal nicotinic acetylcholine receptor antagonist. J Biol Chem 2000; 275: 8680-5.
143. Nicke A, Samochocki M, Loughnan ML, Bansal PS, Maelicke A, Lewis RJ. α-Conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors. FEBS Lett 2003; 554: 219-23.
144. Fainzilber M, Hasson A, Oren R, Burlingame AL, Gordon D, Spira ME, et al. New mollusc-specific α-conotoxins block Aplysia neuronal acetylcholine receptors. Biochemistry 1994; 33: 9523-9.
145. Wolfender JL, Chu F, Ball H, Wolfender F, Fainzilber M, Baldwin MA, et al. Identification of tyrosine sulfation in Conus pennaceus conotoxins α-PnIA and α-PnIB: Further investigation of labile sulfo- and phosphopeptides by electrospray, matrix-assisted laser desorption/ionization (MALDI) and atmospheric pressure MALDI mass spectrometry. J Mass Spectrom 1999; 34: 447-54.
146. Hogg RC, Miranda LP, Craik DJ, Lewis RJ, Alewood PF, Adams DJ. Single amino acid substitutions in α-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor. J Biol Chem 1999; 274: 36559-64.
147. Hu SH, Gehrmann J, Guddat LW, Alewood PF, Craik DJ, Martin JL. The 1.1 Å crystal structure of the neuronal acetylcholine receptor antagonist, α-conotoxin PnIA from Conus pennaceus. Structure 1996; 4: 417-23.
148. Luo S, Nguyen TA, Cartier GE, Olivera BM, Yoshikami D, McIntosh JM. Single-residue alteration in α-conotoxin PnIA switches its nAChR subtype selectivity. Biochemistry 1999; 38: 14542-8.
149. Everhart D, Reiller E, Mirzoian A, McIntosh JM, Malhotra A, Luetje CW. Identification of residues that confer α-conotoxin-PnIA sensitivity on the α3 subunit of neuronal nicotinic acetylcholine receptors. J Pharmacol Exp Ther 2003; 306: 664-70.
150. Dutertre S, Nicke A, Lewis RJ. β2 Subunit contribution to 4/7 α-conotoxin binding to the nicotinic acetylcholine receptor. J Biol Chem 2005; 280: 30460-8.
151. Hu SH, Gehrmann J, Alewood PF, Craik DJ, Martin JL. Crystal structure at 1.1 Å resolution of α-conotoxin PnIB: Comparison with α-conotoxins PnIA and GI. Biochemistry 1997; 36: 11323-30.
152. 10 of α-conotoxin PnIB confers potency for neuronal nicotinic responses in bovine chromaffin cells. Eur J Pharmacol 2000; 390: 229-36.
153. Loughnan M, Bond T, Atkins A, Cuevas J, Adams DJ, Broxton NM, et al. α-Conotoxin EpI, a novel sulfated peptide from Conus episcopatus that selectively targets neuronal nicotinic acetylcholine receptors. J Biol Chem 1998; 273: 15667-74.
154. 15]EpI, a novel α-conotoxin from Conus episcopatus, solved by direct methods. Biochemistry 1998; 37: 11425-33.
155. Loughnan ML, Nicke A, Jones A, Adams DJ, Alewood PF, Lewis RJ. Chemical and functional identification and characterization of novel sulfated α-conotoxins from the cone snail Conus anemone. J Med Chem 2004; 47: 1234-41.
156. Sandall DW, Satkunanathan N, Keays DA, Polidano MA, Liping X, Pham V, et al. A novel α-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. Biochemistry 2003; 42: 6904-11.
157. Clark RJ, Fischer H, Nevin ST, Adams DJ, Craik DJ. The synthesis, structural characterization, and receptor specificity of the α-conotoxin Vc1.1. J Biol Chem 2006; 281: 23254-63.
158. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 1996; 271: 7522-8.
159. 2 neuronal nicotinic acetylcholine receptor-targeted ligand. Biochemistry 1997; 36: 15693-700.
160. Hill JM, Oomen CJ, Miranda LP, Bingham JP, Alewood PF, Craik DJ. Three-dimensional solution structure of α-conotoxin MII by NMR spectroscopy: Effects of solution environment on helicity. Biochemistry 1998; 37: 15621-30.
161. Harvey SC, McIntosh JM, Cartier GE, Maddox FN, Luetje CW. Determinants of specificity for α-conotoxin MII on α3β2 neuronal nicotinic receptors. Mol Pharmacol 1997; 51: 336-42.
162. 3H]dopamine release from rat striatal synaptosomes and slices. J Neurochem 1998; 70: 1069-76.
163. McIntosh JM, Gardner S, Luo S, Garrett JE, Yoshikami D. Conus peptides: Novel probes for nicotinic acetylcholine receptor structure and function. Eur. J. Pharmacol 2000; 393: 205-8.
164. Vailati S, Hanke W, Bejan A, Barabino B, Longhi R, Balestra B, et al. Functional α6-containing nicotinic receptors are present in chick retina. Mol Pharmacol 1999; 56: 11-9.
165. Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Léna C, et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci 2003; 23: 7820-9.
166. McIntosh JM, Azam L, Staheli S, Dowell C, Lindstrom JM, Kuryatov A, et al. Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors. Mol Pharmacol 2004; 65: 944-52.
167. Grinevich VP, Letchworth SR, Lindenberger KA, Menager J, Mary V, Sadieva KA, et al. Heterologous expression of human α6β4β3α5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the α5 subunit. J Pharmacol Exp Ther 2005; 312: 619-26.
168. Gotti C, Moretti M, Zanardi A, Gaimarri A, Champtiaux N, Changeux JP, et al. Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype α3β2(α5 or β3) enriched in retinocollicular afferents. Mol Pharmacol 2005; 68: 1162-71.
169. Cui C, Booker TK, Allen RS, Grady SR, Whiteaker P, Marks MJ, et al. The β3 nicotinic receptor subunit: A component of α-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci 2003; 23: 11045-53.
170. McIntosh JM, Dowell C, Watkins M, Garrett JE, Yoshikami D, Olivera BM. α-Conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors. J Biol Chem 2002; 277: 33610-5.
171. Chi SW, Kim DH, Olivera BM, McIntosh JM, Han KH. Solution conformation of α-conotoxin GIC, a novel potent antagonist of α3β2 nicotinic acetylcholine receptors. Biochem J 2004; 380: 347-52.
172. Nicke A, Loughnan ML, Millard EL, Alewood PF, Adams DJ, Daly NL, et al. Isolation, structure, and activity of GID, a novel α4/ 7-conotoxin with an extended N-terminal sequence. J Biol Chem 2003; 278: 3137-44.
173. Dowell C, Olivera BM, Garrett JE, Staheli ST, Watkins M, Kuryatov A, et al. α-Conotoxin PIA is selective for α6 subunit-containing nicotinic acetylcholine receptors. J Neurosci 2003; 23: 8445-52.
174. Chi SW, Lee SH, Kim DH, Kim JS, Olivera BM, McIntosh JM, et al. Solution structure of α-conotoxin PIA, a novel antagonist of α6 subunit containing nicotinic acetylcholine receptors. Biochem Biophys Res Commun 2005; 338: 1990-7.
175. Whiteaker P, Christensen S, Yoshikami D, Dowell C, Watkins M, Gulyas J, et al. Discovery, synthesis, and structure activity of a highly selective α7 nicotinic acetylcholine receptor antagonist. Biochemistry 2007; 46: 6628-38.
176. Martinez JS, Olivera BM, Gray WR, Craig AG, Groebe DR, Abramson SN, et al. α-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity. Biochemistry 1995; 34: 14519-26.
177. Park KH, Suk JE, Jacobsen R, Gray WR, McIntosh JM, Han KH. Solution conformation of α-conotoxin EI, a neuromuscular toxin specific for the α1/δ subunit interface of Torpedo nicotinic acetylcholine receptor. J Biol Chem 2001; 276: 49028-33.
178. López-Vera E, Aguilar MB, Schiavon E, Marinzi C, Ortiz E, Restano Cassulini R, et al. Novel α-conotoxins from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors. FEBS J 2007; 274: 3972-85.
179. McIntosh JM, Plazas PV, Watkins M, Gomez-Casati ME, Olivera BM, Elgoyhen AB. A novel α-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat α9α10 and α7 nicotinic cholinergic receptors. J Biol Chem 2005; 280: 30107-12.
180. Talley TT, Olivera BM, Han KH, Christensen SB, Dowell C, Tsigelny I, et al. α-Conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as α3β2 and α7 nicotinic acetylcholine receptors. J Biol Chem 2006; 281: 24678-86.
181. Chi SW, Kim DH, Olivera BM, McIntosh JM, Han KH. Solution conformation of a neuronal nicotinic acetylcholine receptor antagonist α-conotoxin OmIA that discriminates α3 vs. α6 nAChR subtypes. Biochem Biophys Res Commun 2006; 345: 248-54.
182. Dutertre S, Ulens C, Büttner R, Fish A, van Elk R, Kendel Y, et al. AChBP-targeted α-conotoxin correlates distinct binding orientations with nAChR subtype selectivity. EMBO J 2007; 26: 3858-67
183. Peng C, Han Y, Sanders T, Chew G, Liu J, Hawrot E, et al. α4/7-conotoxin Lp1.1 is a novel antagonist of neuronal nicotinic acetylcholine receptors. Peptides 2008; doi:10.1016/ j.peptides.2008.05.028.
184. Hogg RC, Hopping G, Alewood PF, Adams DJ, Bertrand D. α-Conotoxins PnIA and [A10L]PnIA stabilize different states of the α7-L247T nicotinic acetylcholine receptor. J Biol Chem 2003; 278: 26908-14.
185. Millard EL, Daly NL, Craik DJ. Structure-activity relationships of α-conotoxins targeting neuronal nicotinic acetylcholine receptors. Eur J Biochem 2004; 271: 2320-6.
186. Utkin YN, Kobayashi Y, Hucho F, Tsetlin VI. Relationship between the binding sites for an α-conotoxin and snake venom neurotoxins in the nicotinic acetylcholine receptor from Torpedo californica. Toxicon 1994; 32: 1153-7.
187. Kreienkamp HJ, Sine SM, Maeda RK, Taylor P. Glycosylation sites selectively interfere with α-toxin binding to the nicotinic acetylcholine receptor. J Biol Chem 1994; 269: 8108-14.
188. Sine SM, Kreienkamp HJ, Bren N, Maeda R, Taylor P. Molecular dissection of subunit interfaces in the acetylcholine receptor: Identification of determinants of α-conotoxin M1 selectivity. Neuron 1995; 15: 205-11.
189. Chiara DC, Xie Y, Cohen JB. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: Affinity-labeling and mutational analyses identify γTyr-111/δArg-113 as antagonist affinity determinants. Biochemistry 1999; 38: 6689-98.
190. Quik M, McIntosh JM. Striatal α6* nicotinic acetylcholine receptors: Potential targets for Parkinson's disease therapy. J Pharmacol Exp Ther 2006; 316: 481-9.
191. Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, et al. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol 2007; 74: 1235-46.
192. Azam L, Yoshikami D, McIntosh JM. Amino acid residues that confer high selectivity of the α6 nicotinic acetylcholine receptor subunit to α-conotoxin MII[S4A,E11A,L15A]. J Biol Chem 2008; 283: 11625-32.
193. Armishaw CJ, Daly NL, Nevin ST, Adams DJ, Craik DJ, Alewood PF. α-Selenoconotoxins, a new class of potent α7 neuronal nicotinic receptor antagonists. J Biol Chem 2006; 281: 14136-43.
194. Innocent N, Livingstone PD, Hone A, Kimura A, Young T, Whiteaker P, et al. α-Conotoxin ArIBV11L,V16D is a potent and selective antagonist at rat and human native α7 nicotinic acetylcholine receptors. J Pharmacol Exp Ther 2008; doi:10.1124/jpet.108.142943.
195. 3H]norepinephrine release from mouse hippocampal synaptosomes. Mol Pharmacol 2006; 70: 967-76.
196. Shiembob DL, Roberts RL, Luetje CW, McIntosh JM. Determinants of α-conotoxin BuIA selectivity on the nicotinic acetylcholine receptor beta subunit. Biochemistry 2006; 45: 11200-7.
197. Satkunanathan N, Livett B, Gayler K, Sandall D, Down J, Khalil Z. α-Conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones. Brain Res 2005; 1059: 149-58
198. Nevin ST, Clark RJ, Klimis H, Christie MJ, Craik DJ, Adams DJ. Are α9α10 nicotinic acetylcholine receptors a pain target for α-conotoxins? Mol Pharmacol 2007; 72: 1406-10.
199. Jakubowski JA, Keays DA, Kelley WP, Sandall DW, Bingham JP, Livett BG, et al. Determining sequences and post-translational modifications of novel conotoxins in Conus victoriae using cDNA sequencing and mass spectrometry. J Mass Spectrom 2004; 39: 548-57.
200. Quinton L, Le Caër JP, Vinh J, Gilles N, Chamot-Rooke J. Fourier transform mass spectrometry: A powerful tool for toxin analysis. Toxicon 2006; 47: 715-26.
201. Gray WR, Luque FA, Galyean R, Atherton E, Sheppard RC, Stone BL, et al. Conotoxin GI: Disulfide bridges, synthesis, and preparation of iodinated derivatives. Biochemistry 1984; 23: 2796-802.
202. 1)conotoxin GI analogs in the mouse diaphragm. Int J Pept Protein Res 1989; 34: 455-62.
203. Kasheverov IE, Zhmak MN, Maslennikov IV, Utkin YN, Tsetlin VI. A comparative study on selectivity of α-conotoxins GI and ImI using their synthetic analogues and derivatives. Neurochem Res 2003; 28: 599-606.
204. Kaerner A, Rabenstein DL. Stability and structure-forming properties of the two disulfide bonds of α-conotoxin GI. Biochemistry 1999; 38: 5459-70.
205. Mok KH, Han KH. NMR solution conformation of an antitoxic analogue of α-conotoxin GI: Identification of a common nicotinic acetylcholine receptor α1-subunit binding surface for small ligands and α-conotoxins. Biochemistry 1999; 38: 11895-904.
206. Zhang R, Snyder G. Factors governing selective formation of specific disulfides in synthetic variants of α-conotoxin. Biochemistry 1991; 30: 11343-8.
207. Kasheverov I, Rozhkova A, Zhmak M, Utkin Y, Ivanov V, Tsetlin VI. Photoactivatable α-conotoxins reveal contacts with all subunits as well as antagonist-induced rearrangements in the Torpedo californica acetylcholine receptor. Eur J Biochem 2001; 268: 3664-73.
208. Zolotarev YA, Bocharov EV, Dadayan AK, Kasheverov IE, Zhmak MN, Maslennikov IV, et al. Study of solid-phase catalytic isotopic exchange of hydrogen in α-conotoxin G1 under the effect of spill-over-tritium. Bioorg Khim 2000; 26: 587-92.
209. Ashcom JD, Stiles BG. Characterization of α-conotoxin interactions with the nicotinic acetylcholine receptor and monoclonal antibodies. Biochem J 1997; 328: 245-50.
210. Schreiter C, Gjoni M, Hovius R, Martinez KL, Segura JM, Vogel H. Reversible sequential-binding probe receptor-ligand interactions in single cells. Chembiochem 2005; 6: 2187-94.
211. 1H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor. FEBS J 2006; 273: 1373-88.
212. Velez-Carrasco W, Valdes S, Agresar L, Lettich A, Guerra AY, Hann RM. α-Conotoxin residues that interact at close range with γ-tyrosine-111 and mutant δ-tyrosine-113 on the Torpedo nicotinic acetylcholine receptor. Biochemistry 2004; 43: 12700-8.
213. Mezo G, Drakopoulou E, Paal V, Rajnavolgyi E, Vita C, Hudecz F. Synthesis and immunological studies of α-conotoxin chimera containing an immunodominant epitope from the 268-284 region of HSV gD protein. J Pept Res 2000; 55: 7-17.
214. Drakopoulou E, Uray K, Mezo G, Price MR, Vita C, Hudecz F. Synthesis and antibody recognition of mucin 1 (MUC1)-α-conotoxin chimera. J Pept Sci 2000; 6: 175-85.
215. Papineni RV, Sanchez JU, Baksi K, Willcockson IU, Pedersen SE. Site-specific charge interactions of α-conotoxin MI with the nicotinic acetylcholine receptor. J Biol Chem 2001; 276: 23589-98.
216. Sugiyama N, Marchot P, Kawanishi C, Osaka H, Molles B, Sine SM, et al. Residues at the subunit interfaces of the nicotinic acetylcholine receptor that contribute to α-conotoxin M1 binding. Mol Pharmacol 1998; 53: 787-94.
217. Cortez L, Marino-Buslje C, de Jiménez Bonino MB, Hellman U. Interactions between α-conotoxin MI and the Torpedo marmorata receptor α-δ interface. Biochem Biophys Res Commun 2007; 355: 275-9.
218. Bren N, Sine SM. Hydrophobic pairwise interactions stabilize α-conotoxin MI in the muscle acetylcholine receptor binding site. J Biol Chem 2000; 275: 12692-700.
219. Hargittai B, Barany G. Controlled syntheses of natural and disul-fide-mispaired regioisomers of α-conotoxin SI. J Pept Res 1999; 54: 468-79.
220. Hargittai B, Sole NA, Groebe DR, Abramson SN, Barany G. Chemical syntheses and biological activities of lactam analogues of α-conotoxin SI. J Med Chem 2000; 43: 4787-92.
221. Servent D, Thanh HL, Antil S, Bertrand D, Corringer PJ, Changeux JP, et al. Functional determinants by which snake and cone snail toxins block the α7 neuronal nicotinic acetylcholine receptors. J Physiol (Paris) 1998; 92: 107-11.
222. Lamthanh H, Jegou-Matheron C, Servent D, Menez A, Lancelin JM. Minimal conformation of the α-conotoxin ImI for the α7 neuronal nicotinic acetylcholine receptor recognition: Correlated CD, NMR and binding studies. FEBS Lett 1999; 454: 293-8.
223. Kang TS, Vivekanandan S, Jois SD, Kini RM. Effect of C-terminal amidation on folding and disulfide-pairing of α-conotoxin ImI. Angew Chem Int Ed Engl 2005; 44: 6333-7.
224. Utkin YN, Zhmak MN, Methfessel C, Tsetlin VI. Aromatic substitutions in α-conotoxin ImI. Synthesis of iodinated photoactivatable derivative. Toxicon 1999; 37: 1683-95.
225. Quiram, P.A. and Sine, S.M. Structural elements in α-conotoxin ImI essential for binding to neuronal α7 receptors. J Biol Chem 1998; 273: 11007-11.
226. Rogers JP, Luginbuhl P, Pemberton K, Harty P, Wemmer DE, Stevens RC. Structure-activity relationships in a peptidic α7 nicotinic acetylcholine receptor antagonist. J Mol Biol 2000; 304: 911-26.
227. Kumar P, Meizel S. Nicotinic acetylcholine receptor subunits and associated proteins in human sperm. J Biol Chem 2005; 280: 25928-35
228. Quiram PA, Jones JJ, Sine SM. Pairwise interactions between neuronal α7 acetylcholine receptors and α-conotoxin ImI. J Biol Chem 1999; 274: 19517-24.
229. Celie PH, Kasheverov IE, Mordvintsev DY, Hogg RC, van Nierop P, van Elk R, et al. Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an α-conotoxin PnIA variant. Nat Struct Mol Biol 2005; 12: 582-8.
230. Jin AH, Daly NL, Nevin ST, Wang CI, Dutertre S, Lewis RJ, et al. Molecular engineering of conotoxins: The importance of loop size to α-conotoxin structure and function. J Med Chem 2008; 51: 5575-84.
231. 7 acetylcholine receptors and α-conotoxin PnIB. J Biol Chem 2000; 275: 4889-96.
232. 125I-α-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol. Pharmacol 2000; 57: 913-25.
233. Champtiaux N, Han ZY, Bessis A, Rossi FM, Zoli M, Marubio L, et al. Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci 2002; 22: 1208-17.
234. Whiteaker P, Peterson CG, Xu W, McIntosh JM, Paylor R, Beaud et al., et al. Involvement of the α3 subunit in central nicotinic binding populations. J. Neurosci 2002; 22: 2522-9.
235. Salminen O, Whiteaker P, Grady SR, Collins AC, McIntosh JM, Marks MJ. The subunit composition and pharmacology of α-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay. Neuropharmacology 2005; 48: 696-705.
236. Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, Grady SR. Pharmacology of α-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Mol Pharmacol 2007; 71: 1563-71.
237. Bordia T, Grady SR, McIntosh JM, Quik M. Nigrostriatal damage preferentially decreases a subpopulation of α6β2* nAChRs in mouse, monkey, and Parkinson's disease striatum. Mol Pharmacol 2007; 72: 52-61.
238. Doura MB, Gold AB, Keller AB, Perry DC. Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res 2008; 1215: 40-52.
239. Clark RJ, Fischer H, Dempster L, Daly NL, Rosengren KJ, Nevin ST, et al. Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the α-conotoxin MII. Proc Natl Acad Sci USA 2005; 102: 13767-72.
240. Vishwanath VA, McIntosh JM. Synthesis of fluorescent analogs of α-conotoxin MII. Bioconjug Chem 2006; 17: 1612-7.
241. Everhart D, Cartier GE, Malhotra A, Gomes AV, McIntosh JM, Luetje CW. Determinants of potency on α-conotoxin MII, a peptide antagonist of neuronal nicotinic receptors. Biochemistry 2004; 43: 2732-7.
242. Blanchfield JT, Dutton JL, Hogg RC, Gallagher OP, Craik DJ, Jones A, et al. Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of α-conotoxin MII. J Med Chem 2003; 46: 1266-72.
243. Blanchfield JT, Gallagher OP, Cros C, Lewis RJ, Alewood PF, Toth I. Oral absorption and in vivo biodistribution of a α-conotoxin MII and a lipidic analogue. Biochem Biophys Res Commun 2007; 361: 97-102
244. 125I-α-conotoxin ArIB[V11L;V16A], a selective α7 nicotinic acetylcholine receptor antagonist. J Pharmacol Exp Ther 2008; 325: 910-9.
245. Craik DJ, Adams DJ. Chemical modification of conotoxins to improve stability and activity. ACS Chem Biol 2007; 2: 457-68.
246. Williams JA, Day M, Heavner JE. Ziconotide: An update and review. Expert Opin Pharmacother 2008; 9: 1575-83.
247. Quiram PA, Sine SM. Identification of residues in the neuronal α7 acetylcholine receptor that confer selectivity for conotoxin ImI. J Biol Chem 1998; 273: 11001-6.
248. Sine SM. The nicotinic receptor ligand binding domain. J Neurobiol 2002; 53: 431-46.
249. Smit AB, Syed NI, Schaap D, van Minnen J, Klumperman J, Kits KS, et al. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 2001; 411: 261-8.
250. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001; 411: 269-76.
251. Hansen SB, Talley TT, Radic Z, Taylor P. Structural and ligand recognition characteristics of an acetylcholine-binding protein from Aplysia californica. J Biol Chem 2004; 279: 24197-202.
252. Celie PH, Klaassen RV, van Rossum-Fikkert SE, van Elk R, van Nierop P, Smit AB, et al. Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors. J Biol Chem 2005; 280: 26457-66.
253. Kasheverov IE, Utlin YN, Tsetlin VI. Natural α-conotoxins and their synthetic analogues in study of nicotinic acetylcholine receptors. Russ J Bioorg Chem 2006; 32: 103-115.
254. Hansen SB, Sulzenbacher G, Huxford T, Marchot P, Taylor P, Bourne Y. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J 2005; 24: 3635-46.
255. Ulens C, Hogg RC, Celie PH, Bertrand D, Tsetlin V, Smit AB, et al. Structural determinants of selective α-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP. Proc Natl Acad Sci USA 2006; 103: 3615-20.
256. Gao F, Bren N, Burghardt TP, Hansen S, Henchman RH, Taylor P, et al. Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence. J Biol Chem 2005; 280: 8443-51.
257. Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution. J Mol Biol 2005; 346: 967-89.